Les Laboratoires Servier - SWOT, Strategy and Corporate Finance Report

Date: June 26, 2013
Pages: 32
Price:
US$ 175.00
License [?]:
Publisher: MarketLine
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: L6EF2D7497DEN
Leaflet:

Download PDF Leaflet

Les Laboratoires Servier - SWOT, Strategy and Corporate Finance Report
Les Laboratoires Servier - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:
  • Detailed information on Les Laboratoires Servier required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Les Laboratoires Servier in the form of a SWOT analysis
  • An in-depth view of the business model of Les Laboratoires Servier including a breakdown and examination of key business segments
  • Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Les Laboratoires Servier
  • Intelligence on Les Laboratoires Serviernv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Les Laboratoires Servier, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Les Laboratoires Servier (Servier or 'the company') is the leading independent pharmaceutical company in France. The company focuses primarily in the therapeutic areas of neurosciences, oncology, cardiovascular disease, metabolic disease, rheumatology, and basic research. The company operates in 140 countries. It is headquartered in Neuily-Sur-Seine, France, and employs about 20,000 people. The company reported revenues of E3,900 million ($5,014.6 million) during the financial year ended December 2012 (FY2012). Servier is a privately-held pharmaceutical company and it does not release financial statements. Hence, the company's financial details such as operating and net profits are not available. Calculated using a constant conversion rate of E1 = $1.2858 for the year ended December 31, 2012.

Reasons to Purchase:
  • Gain understanding of Les Laboratoires Servier and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Les Laboratoires Servier as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Les Laboratoires Servier’s business structure, strategy and prospects
COMPANY SNAPSHOT

Les Laboratoires Servier: Company Overview
Les Laboratoires Servier: Overview and Key Facts
  Les Laboratoires Servier: Overview
  Les Laboratoires Servier: Key Facts
Les Laboratoires Servier: Key Employees
Les Laboratoires Servier: Major Products and Services
Les Laboratoires Servier: Company History
Les Laboratoires Servier: Management Statement
Les Laboratoires Servier: Locations and Subsidiaries
Les Laboratoires Servier: Key Competitors

LES LABORATOIRES SERVIER: COMPANY ANALYSIS

Les Laboratoires Servier: Business Description
Les Laboratoires Servier: SWOT Analysis
  Les Laboratoires Servier: SWOT Overview
  Les Laboratoires Servier: Strengths
  Les Laboratoires Servier: Weaknesses
  Les Laboratoires Servier: Opportunities
  Les Laboratoires Servier: Threats
Les Laboratoires Servier: Corporate Financial Deals Activity
Les Laboratoires Servier: Financial Deals Overview
Les Laboratoires Servier: Targets and Partners
Les Laboratoires Servier: Top Deals 2009 - 2013YTD
Les Laboratoires Servier: Mergers and Acquisitions
Les Laboratoires Servier: Partnership

LES LABORATOIRES SERVIER: RECENT DEVELOPMENTS

Les Laboratoires Servier: News and Events Summary
Les Laboratoires Servier: Contracts
Les Laboratoires Servier: Research & Development

APPENDIX

Contact Us
Methodology
Definitions
About Datamonitor

LIST OF TABLES

Table 1: Les Laboratoires Servier: Key Facts
Table 2: Les Laboratoires Servier: Key Employees
Table 4: Les Laboratoires Servier: Key Competitors
Table 5: Les Laboratoires Servier: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Les Laboratoires Servier: Deal Activity by Deal Type - Volume (2009 - YTD 2013)
Table 7: Les Laboratoires Servier: Targets and Partners
Table 8: Les Laboratoires Servier: Top Deals 2009 - 2013YTD
Table 9: Les Laboratoires Servier: M&A Volume and Value Trend (2009 - YTD 2013)
Table 10: Les Laboratoires Servier: M&A Activity by Geography (2009 - YTD 2013)
Table 11: Les Laboratoires Servier: Partnership Volume and Value Trend (2009 - YTD 2013)
Table 12: Les Laboratoires Servier: Partnership Trend by Deal Type (2009 - YTD 2013)
Table 13: Les Laboratoires Servier: News and Events Summary
Table 14: Les Laboratoires Servier: Contracts
Table 15: Les Laboratoires Servier: Research & Development

LIST OF FIGURES

Figure 1: Les Laboratoires Servier: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Les Laboratoires Servier: Deal Activity by Deal Type - Volume (2009 - YTD 2013)
Figure 3: Les Laboratoires Servier: M&A Volume and Value Trend (2009 - YTD 2013)
Figure 4: Les Laboratoires Servier: M&A Activity by Geography (2009 - YTD 2013)
Figure 5: Les Laboratoires Servier: Partnership Volume and Value Trend (2009 - YTD 2013)
Figure 6: Les Laboratoires Servier: Partnership Trend by Deal Type (2009 - YTD 2013)
Les Laboratoires Servier - SWOT Analysis US$ 175.00 Jun, 2011 · 18 pages
Les Laboratoires Servier: PharmaVitae Profile US$ 5,700.00 Nov, 2010 · 101 pages

Ask Your Question

Les Laboratoires Servier - SWOT, Strategy and Corporate Finance Report
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: